Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSomero Regulatory News (SOM)

Share Price Information for Somero (SOM)

Share Price is delayed by 15 minutes
Get Live Data
189.50    0.00 (0.00%)
Bid:
189.00
Ask:
190.00
Spread: 1.00 (0.529%)
Market Cap: £100.37m
SOM Live PriceLast checked at - London Stock Exchange

Intraday Somero Share Chart

Trading Update

19 Jul 2022 07:00

RNS Number : 8731S
Somero Enterprises Inc.
19 July 2022
 

19 July 2022

Somero Enterprises, Inc.

("Somero" or "the Company")

 

Trading Update

Somero® is pleased to provide an update on trading ahead of its interim results announcement scheduled to be released on Wednesday, 7 September 2022.

Driven by positive momentum from a highly active US non-residential construction market, healthy market conditions and elevated activity levels in the European and Australian markets, Group trading in H1 2022 ended higher than the comparable H1 2021 period. 

 

As expected, H1 2022 trading in North America remained strong, increasing from H1 2021, reflective of customers with sizable workloads and project backlogs that extend well into 2023. The breadth and variety of project activity in the US translated to healthy take rates across the Somero product portfolio including continued, strong performance in the boomed screed category.

 

The European market was active during H1 2022, reflective of positive non-residential construction market conditions and a busy customer base with healthy, extended project backlogs. While H1 2022 trading in Europe was down compared to H1 2021, due largely to logistics challenges that delayed machine shipments, based on the H1 2022 momentum and activity levels alongside anticipated catch-up on shipment delays to start H2 2022, second half 2022 trading is anticipated to accelerate, and Europe is anticipated to contribute to full-year 2022 growth. 

 

H1 2022 trading in Australia was also strong, improving from H1 2021, reflecting similar positive market conditions as the US and Europe, in line with the expectation that the region will contribute meaningfully to 2022 growth. Trading in all other regions also fell in line with expectations, including in China where revenues were down compared to H1 2021 due to the previously announced reduced Company focus on the region and the severe impact of COVID restrictions. 

 

New products, including the SkyScreed®, the S-PS50 Laser Screed® and the Somero Broom+CureTM, contributed meaningfully to H1 2022 sales while the Company continues to make good progress in identifying opportunities to penetrate untapped market segments and with development of new solutions for customers.

 

During the first six months of 2022, the also Company made substantial progress with the Houghton, Michigan building expansion project anticipated to be completed by the end of Q3 2022 and with adding new personnel necessary to support future growth of the business, particularly in our primary US, Europe and Australian markets. 

 

While cognizant of the uncertain macro economic environment, the Board continues to anticipate healthy trading to continue in H2 2022, a view underpinned by direct feedback from customers in the US, Europe & Australian indicating high workloads and extended project backlogs. As such, the Board is pleased to confirm 2022 results are anticipated to fall in line with market expectations for revenues of approximately US$ 138.8m, EBITDA of approximately US$ 47.7m, and year-end cash of approximately US$ 39.9m.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be in the public domain.

 

Enquiries:

 

Somero Enterprises, Inc. www.somero.com

Jack Cooney, CEO +1 239 210 6500

John Yuncza, President

Vincenzo LiCausi, CFO

Howard Hohmann, EVP Sales

 

finnCap Ltd (NOMAD and Broker)

Matt Goode (Corporate Finance) +44 (0)20 7220 0500

Kate Bannatyne (Corporate Finance)

Tim Redfern/Richard Chambers (ECM)

 

Alma PR (Financial PR Advisor) somero@almapr.co.uk

David Ison +44 (0)20 3405 0205

Pippa Crabtree

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKFBKABKDAOD
Date   Source Headline
21st Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Nov 20259:01 amRNSTransaction in Own Shares and Total Voting Rights
18th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Nov 20253:12 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Nov 20252:13 pmRNSTransaction in Own Shares and Total Voting Rights
11th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Nov 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Oct 20257:00 amRNSHolding(s) in Company
14th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20254:50 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Sep 20256:01 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20254:28 pmRNSHolding(s) in Company
10th Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Aug 20257:01 amRNSTransaction in Own Shares and Total Voting Rights
18th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20257:00 amRNSNotice of Results and Investor Presentation
8th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20257:00 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20257:00 amRNSTrading Update
23rd Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Jul 20257:00 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Jul 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Jun 20254:16 pmRNSResult of AGM
17th Jun 20257:50 amRNSAGM Statement
6th Jun 20255:29 pmRNSHolding(s) in Company
6th Jun 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
21st May 20252:19 pmRNSRestricted Stock Units, Director/PDMR Shareholding
12th May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th May 20257:00 amRNSRestricted Stock Units, Director/PDMR Shareholding
1st May 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
1st May 20257:00 amRNSAnnual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.